Shares of PURE Bioscience (OTCMKTS:PURE – Get Free Report) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.06 and traded as high as $0.06. PURE Bioscience shares last traded at $0.0591, with a volume of 161,093 shares changing hands.
PURE Bioscience Stock Up 7.4%
The firm has a 50-day moving average of $0.05 and a two-hundred day moving average of $0.06. The company has a market capitalization of $7.11 million, a PE ratio of -2.12 and a beta of 0.52.
About PURE Bioscience
PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.
PURE’s product suite includes concentrate formulations and ready-to-use solutions.
Featured Stories
- Five stocks we like better than PURE Bioscience
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
